New developments in the treatment of multiple myeloma – clinical utility of daratumumab

Por McEllistrim, Cian, Krawczyk, Janusz, O’Dwyer, Michael E
Publicado no Biologics (2017)

The BH3-mimetic ABT-737 effectively kills acute myeloid leukemia initiating cells

Por Baev, Denis V., Krawczyk, Janusz, O׳Dwyer, Michael, Szegezdi, Eva
Publicado em 2014

Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring

Por Langabeer, Stephen E., McCarron, Sarah L., Kelly, Johanna, Krawczyk, Janusz, McPherson, Suzanne, Perera, Kanthi, Murphy, Philip T.
Publicado em 2012

Platelet-rich plasma (PRP) therapy for knee arthritis: a feasibility study in primary care

Por Glynn, Liam G., Mustafa, Alaa, Casey, Monica, Krawczyk, Janusz, Blom, Jeanete, Galvin, Rose, Hannigan, Ailish, Dunne, Colum P., Murphy, Andrew W., Mallen, Christian
Publicado no Pilot Feasibility Stud (2018)

Rapamycin regulates autophagy and cell adhesion in induced pluripotent stem cells

Por Sotthibundhu, Areechun, McDonagh, Katya, von Kriegsheim, Alexander, Garcia-Munoz, Amaya, Klawiter, Agnieszka, Thompson, Kerry, Chauhan, Kapil Dev, Krawczyk, Janusz, McInerney, Veronica, Dockery, Peter, Devine, Michael J., Kunath, Tilo, Barry, Frank, O’Brien, Timothy, Shen, Sanbing
Publicado no Stem Cell Res Ther (2016)